Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 5c; Guides FY11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 231.32 +16.88 (7.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.44 | 52 Week High | $160.00 | |||
| Open | $225.37 | 52 Week Low | $95.80 | |||
| Day High | $233.74 | P/E | 43.00 | |||
| Day Low | $218.53 | EPS | $5.38 | |||
| Volume | 597,468 | |||||
